Overview
A Liver-Targeted *CIDEB* siRNA in Adults with MASLD
Nov 8, 2026DOI: 10.1056/nejmc2612905CorrespondenceNEJM
Written by: Thomas D. Norton, M.D.Jorg Taubel, M.D.Gavin H. Imperato, M.D., Ph.D.Sonya Aziz-Zaman, M.S.Jane Witkin, Pharm.D.Jutta Miller, R.N.Kusha A. Mohammadi, Ph.D.Shunguang Wang, Ph.D.Terri Swanson, M.A.Madison Stoms, Ph.D.Xiping Cheng, Ph.D.Jessica D’Antonio, M.B.A.Shehla Habib, B.S.David Workman, M.B.A.Justin Cho, M.S.Yogesh Patel, Ph.D.Vidya Xavier, M.Pharm.Chao Chen, Ph.D.David J. Smith, Ph.D.Sean Smith, Pharm.D.Susana Pereira, B.S.Donato Forlenza, Pharm.D.Joette Pindar, M.S.Meredith Crosby, Ph.D.Shawn Fidotta, B.S.Mauricio Leal, Ph.D.Fady Tanios, Ph.D.Viktoria Gusarova, Ph.D.Mark Sleeman, Ph.D.Jennifer Hamilton, Ph.D.John Davis, Ph.D.Dinko Gonzalez Trotter, Ph.D.Rong Liu, M.D., Ph.D.Bret Musser, Ph.D.Ed Cox, M.D.Ned Braunstein, M.D.Niek Verweij, Ph.D.Luca A. Lotta, M.D., Ph.D.George D. Yancopoulos, M.D., Ph.D.Aris Baras, M.D.Gary A. Herman, M.D.David J. Lederer, M.D.
